Sterling Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.98K Sell
137
-154
-53% -$5.6K ﹤0.01% 2517
2025
Q1
$10.5K Sell
291
-1,166
-80% -$42.2K ﹤0.01% 1845
2024
Q4
$61.3K Sell
1,457
-183
-11% -$7.7K ﹤0.01% 1559
2024
Q3
$91.1K Buy
+1,640
New +$91.1K ﹤0.01% 1407